The recently proposed Research Domain Criteria (RDoC) system defines psychopathologies as phenomena of multilevel neurobiological existence and assigns them to 5 behavioural domains characterizing a brain in action. We performed an analysis on this contemporary concept of psychopathologies in respect to a brain phylogeny and biological substrates of psychiatric diseases. We found that the RDoC system uses biological determinism to explain the pathogenesis of distinct psychiatric symptoms and emphasises exploration of endophenotypes but not of complex diseases. Therefore, as a possible framework for experimental studies it allows one to evade a major challenge of translational studies of strict disease-to-model correspondence. The system conforms with the concept of a normality and pathology continuum, therefore, supports basic studies. The units of analysis of the RDoC system appear as a novel matrix for model validation. The general regulation and arousal, positive valence, negative valence, and social interactions behavioural domains of the RDoC system show basic construct, network, and phenomenological homologies between human and experimental animals. The nature and complexity of the cognitive behavioural domain of the RDoC system deserve further clarification. These homologies in the 4 domains justifies the validity, reliably and translatability of animal models appearing as endophenotypes of the negative and positive affect, social interaction and general regulation and arousal systems' dysfunction.
Diagnosis of psychopathologies is mostly based on the presence of deviant behaviour, self-evaluated discontent, behavioural maladaptation and danger posed to the patient or others. The categorical assignment of illnesses is justified by practical needs, such as unification of data across medical institutions, statistics, on default diagnostic efforts and treatment and on official grounds of reimbursement for a diagnostic means and therapeutic interventions by health insurance companies. However, diagnostic complexity and the lack of confidence in the final diagnosis often result in a formal use of contemporary nosological classifications (Maj, 2015) .
Nosological entities imply the existence of specific causations. As a result, major efforts have been made to try to identify specific hallmarks of pathogenesis or associated genes using objective measurements in order to gain a high level of diagnostic reliability. Jaspers (1913) insisted that a nosological entity is a goal for study, but not an objectively existing phenomenon. Thus, any nosological approach to stratify disease should be viewed as a diagnostic strategy rather than approach to research distinct pathogenesis.
Evolutional and Neurobiological Understanding of Psychopathology
MacLean (1970, 1985, and 1990) 
The RDoC System as a New Framework for Categorizing Psychopathologies
The The RDoC system has several advantages as a framework for guiding preclinical studies: However, despite its clear advantages, the RDoC system also bears a few shortcomings:
(1) The RDoC system does not explicitly take into consideration the developmental and dynamical aspect of psychiatric disease, but only acknowledges their importance (Owen, 2014) . (2) 
Neurobiological coordinates for experimental phenotypes and the RDoC system

Requirements for experimental models of psychopathological states
The deterministic principle in biology represents a powerful way to understand the biological processes that shape both normality and abnormality. In psychiatry, this principle goes back to Griesinger (1845) who put forward the brain as a substrate of psychiatric illnesses. Today, psychiatric disorders are seen as a result of an interaction between intrinsic and environmental factors. Therefore, a model system should be conceived as a combination of the experimental subject and applied test situation.
Today we acknowledge the probabilistic aspects of disease that require a combination of The RDoC system is a platform that aims to improve translatability of studies from animals to humans, since it supports the endophenotype-based comparison of animals and humans on an objective neurobiological basis across all behavioural domains. The idea of using observable and objectively measured behaviour to create animal models of pathology had already been introduced (Geyer and Moghaddam, 2002; Segal and Geyer, 1985) . The RDoC system advanced to allow the models to be systematized and grouped, which makes the behavioural endophenotype the primary focus. The RDoC system offers a useful validation matrix, where the units of analysis serve as criteria and, together with the domains, it may be feasible to delineate the areas of homologies between animal and humans. The RDoc system provides a conceptual approach to study of abnormal endophenotypes considering them as a deviation of normality. Therefore, it strongly supports basic/disease focused studies (Bertuzzi and Cleveland, 2015) and justifies using experimental animals to better understand pathological processes.
Fitting The Affective Neuroscience Scale
We assume that the most reliable comparison between animals and humans can be done within the 4 RDoC domains, which describe basic emotions and defence responses.
These domains fully overlap with The Affective Neuroscience Scale (Figure 2 ). For instance, the negative valence systems domain includes the "Fear" and "Panic" systems.
The positive valence systems domain, in turn, includes the systems responsible for feelings of pleasure and attachment ("Play", "Care", "Lust", and "Seeking"). The arousal and regulatory systems combines "Play", "Seeking", and "Rage" clusters. The social processes domain can be defined as a constellation of the "Play" and "Care". The 
Concerning the cognitive systems domain
The fifth domain of the RDoC system, the cognitive system is the loose accumulation of a variety of cognitive functions (i.e., perception, attention, declarative memory, The multidomain assignment might be particularly promising if, for instance, the positive and negative valences are considered as both function and argument of the cognitive system. For instance, effective stress coping is a cognitive system-controlled transition from negative affect to positive affect ( Figure 3 ). In general, the objective difference between the complexity of interactions in the cognitive and affective systems in small experimental animals and humans provide strong limitations for modelling and studying cognitive disturbances in mice and rats.
Putting animal and human behavioural endophenotypes in a right perspective
Difficulties, which appear when matching animal and human behavioural traits and responses (Nestler and Hyman, 2010), might be resolved in the following ways: 1. A model should be perceived as an endophenotype/ symptom-based model and considered only as biological system representing a distinct pathological process, but not a nosological entity.
2. A pathological process must be defined in respect to a particular concept of pathogenesis of psychopathologies. For instance, it might be seen as an imbalance between cortical and subcortical structures or as a state of wrong employment of a generally adaptive process. This will define the interpretation and limit possible misinterpretations acquired due to a deductive analysis (Poldrack, 2006) . 
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Matching of pathological symptoms and experimental endophenotypes
Based on the RDoC, the following principles can be applied to better model pathology in animals:
• Assume a model is an endophenotype model (symptom-based);
• Assign the experimental endophenotype to 1 of the 5 RDoC domains;
• Identify corresponding symptoms in humans in the same domain;
• Reveal a spectrum of related clinical symptoms preferentially within a single syndrome;
• Examine whether developmental, dynamic and co-morbidity features of the experimental endophenotype fit to the particular syndrome corresponding to a nosological entity.
• Since disturbance in the cognitive system is a characteristic feature of psychopathology, evaluation of cognitive function (in terms of modality and intensity of changes) should be an ultimate step in proposing the phenotype as a psychiatric disease model.
Conclusions
The recently proposed RDoC diagnostic framework is a new strategy of symptom-based classification. It revives and upgrades the idea of characterizing the basic function of brain rather than the typical pathological traits (Schneider, 1959) . The RDoC system exploits objective measurements at all levels of neurobiological investigation from molecules to circuits and behaviour and offers a biological basis of diagnosis.
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At present, the proposed system is still mechanistic and its nosology-dissecting and aetiology-finding abilities are a matter of debate. However, the reductionism of the RDoC system makes it an important methodological tool. The RDoC system offers a good platform for the integral study of clinical data and for the critical evaluation of existing animal models based on systematic examination of endophenotypes.
To summarise our analysis of the RDoC system, we may conclude that:
1.
The RDoC system implies the same mechanisms underlie normal and dysfunctional brain function. The RDoc system also suggests the existence of a psychopathological continuum.
2.
In the present state, the RDoC system does not consider dynamical and developmental aspects of a disease, psychosomatic co-morbidities, paradigms of therapeutic interventions nor interactions between domain and components of Units of Analysis.
3.
Four of the 5 RDoC domains correspond to The Affective Neuroscience Scale. A homology of the affective systems in humans and animals supports experimental models of the emotion and defence response dysfunction. However, the high translational value of these models is limited by the dissimilarities between developmental programs and psycho-social contexts of human disorders.
4.
Nonetheless, the RDoC system offers a valid and instructive framework for basic research allowing one to focus on domains and their constructs and to explore endophenotype-based models. This avoids a major challenge of translational studies, which assume a strict disease-to-model correspondence.
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